Nucleic acid therapeutics: State of the art and future prospects

被引:222
作者
Gewirtz, AM
Sokol, DL
Ratajczak, MZ
机构
[1] Univ Penn, Sch Med, Stellar Chance Labs 513B, Dept Internal Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
关键词
D O I
10.1182/blood.V92.3.712.415a32_712_736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:712 / 736
页数:25
相关论文
共 270 条
[41]   A comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations [J].
Chasty, R ;
Whetton, A ;
Lucas, G .
LEUKEMIA RESEARCH, 1996, 20 (05) :391-395
[42]  
CHAVANY C, 1995, MOL PHARMACOL, V48, P738
[43]   SYNTHESIS OF OLIGODEOXYRIBONUCLEOTIDE N3'-]P5' PHOSPHORAMIDATES [J].
CHEN, JK ;
SCHULTZ, RG ;
LLOYD, DH ;
GRYAZNOV, SM .
NUCLEIC ACIDS RESEARCH, 1995, 23 (14) :2661-2668
[44]  
CLARENC JP, 1993, J BIOL CHEM, V268, P5600
[45]   POOR CELLULAR UPTAKE OF ANTISENSE OLIGODEOXYNUCLEOTIDES - AN OBSTACLE TO THEIR USE IN CHRONIC MYELOID-LEUKEMIA [J].
CLARK, RE .
LEUKEMIA & LYMPHOMA, 1995, 19 (3-4) :189-195
[46]   HIGH-EFFICIENCY RECEPTOR-MEDIATED DELIVERY OF SMALL AND LARGE (48 KILOBASE GENE CONSTRUCTS USING THE ENDOSOME-DISRUPTION ACTIVITY OF DEFECTIVE OR CHEMICALLY INACTIVATED ADENOVIRUS PARTICLES [J].
COTTEN, M ;
WAGNER, E ;
ZATLOUKAL, K ;
PHILLIPS, S ;
CURIEL, DT ;
BIRNSTIEL, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :6094-6098
[47]  
COTTER FE, 1994, ONCOGENE, V9, P3049
[48]   ANTISENSE TECHNOLOGY [J].
CROOKE, ST .
CURRENT OPINION IN BIOTECHNOLOGY, 1991, 2 (02) :282-287
[49]  
Crooke Stanley T., 1997, V40, P1
[50]   TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J].
CRYSTAL, RG .
SCIENCE, 1995, 270 (5235) :404-410